Title: References

Value:
  reflist33emrefs   ref name  calia2014     cite news  authorcalia  michael  titlefda imposes partial hold oncomed earlystage cancerdrug trial  date13 jun 2014  work   the wall street journal    urlhttps  onlinewsjcomarticlesoncomedhaltsearlystagetrialsfortwocancerdrugs1402665121    ref    ref name  chidirectorbio     cite web  titlepaul hastings  publisher   california healthcare institute    websiteleadership  urlhttp  wwwchiorgaboutleadershiphastingsaspx  urlstatusdead  archivedate2 october 2011  archiveurlhttps  webarchiveorgweb20111002104016http  wwwchiorgaboutleadershiphastingsaspx    ref    ref name  de2014     cite news  authorde  kanak kanti  titleis it time to consider oncomed pharmaceuticals again   date14 oct 2014  work   seeking alpha    urlhttp  seekingalphacomarticle2560445isittimetoconsideroncomedpharmaceuticalsagain    ref    ref name  demcizumab_usan     cite web  titlestatement a nonproprietary name adopted by the usan council  urlhttps  downloadamaassnorgresourcesdocusanxpubdemcizumabpdf  cb1417490455  retrieveyes  formatpdf  accessdate1 dec 2014  idn1207  publisher   american medical associationama       registration required    ref    ref name  genengbionews2014collab     cite news  titleoncomed  celgene in  33b cancer stem cell collaboration  authorstaff  datejanuary 1  2014  page8  work   gen  eng  biotechnol  news    departmentindustry watch    ref    ref name  grover2014     cite news  work   reuters    authorgrover  natalie  titleoncomed halts enrollment in trials of two cancer drugs  date13 jun 2014  urlhttps  wwwreuterscomarticleusoncomedstudyiduskbn0eo1b920140613    ref    ref name  leuty2007     cite news  authorleuty  ron  titlethe next big thing  oncomed finds a home  date28 oct 2007  work   san francisco business times    urlhttp  wwwbizjournalscomsanfranciscostories20071029focus6html  pageall    ref    ref name  leuty2014     cite news  authorleuty  ron  titleoncomed targets 4 million shares in ipo  date5 jul 2013  work   san francisco business times    urlhttp  wwwbizjournalscomsanfranciscoblogbiotech201307oncomedipocancerstemcellsbayergskhtml    ref    ref name  omppr2013     cite press release  publisheroncomed  titleoncomed pharmaceuticals initiates phase 1b2 clinical trial of anticancer stem cell therapeutic omp59r5  antinotch23  in small cell lung cancer  sclc  and amends phase1b2 pancreatic cancer trial  urlhttp  filesshareholdercomdownloadsamda20k1sk3646503054x0x675682d0fd1bf75edd4aa28dcae525ac9867a2675682pdf  date14 may 2013    ref    ref name  timmerman2013     cite news  authortimmerman  luke  work   xconomy    locationunited states  date18 jun 2013  titleoncomed pharmaceuticals soars in ipo debut  urlhttp  wwwxconomycomsanfrancisco20130718oncomedpharmaceuticalssoarsinipodebut    ref    ref name  uofmhs2013pr     cite press release  publisher   university of michigan health system    titleum startup oncomed has initial public offering  date22 jul 2013  urlhttp  wwwuofmhealthorgnewsarchive201307umstartoncomedhasinitialpublicoffering    ref    ref name  vantictumab_usan     cite web  titlestatement a nonproprietary name adopted by the usan council  urlhttps  downloadamaassnorgresourcesdocusanxpubvantictumabpdf  cb1417489538  retrieveyes  formatpdf  date28 nov 2012  idn12155  publisher   american medical associationama       registration required    ref   